MERCK SERONO awarded its first Grant for Oncology Innovation, who will receive grants totaling EUR 1 million. The grant supports researchers focused on personalized treatment of solid tumors.
The 2014 winners were formally announced at the annual meeting of the European Society for Medical Oncology in Madrid. They are:
Clara Montagut, of Hospital del Mar, in Barcelona, Spain; for proposed research on ultra-selection and molecular monitoring of CRC patients treated with anti-EGFR therapy using NGS platforms and serial liquid biopsies.
Stefan Sleijfer, of the Erasmus MC Cancer Institute, in Rotterdam, Netherlands; for proposed research on non-invasive monitoring of breast cancer therapy using cell-free tumor DNA in blood.
Ulrich Güller, of Cantonal Hospital, in St. Gallen, Switzerland; for a prospective, double-blinded, placebo-controlled, phase III randomized trial of adjuvant aspirin treatment in PIK3CA mutated colon cancer patients.
